One of our senior epidemiologists, Hannah Sally, recently spoke to Verywell Health about vaccine effectiveness - see more here:
https://t.co/CMQcorgSuA
#Covid19#vaccines#longcovid#Pharmaceuticals
In an interview with @Pharmacy_Times, Pamela Spicer, our senior analyst, said the various controversies surrounding the @US_FDA approval of #aducanumab could impact its implementation in health systems:
https://t.co/l9MrlMKWSf
#Alzheimers#Pharma#healthcare
In an interview with @Pharmacy_Times, Pamela Spicer, our senior analyst at @Pharma_Intell, reviewed the 2 pivotal phase 3 clinical trials supporting the @US_FDA's recent approval of #aducanumab. Watch the interview:
https://t.co/MMrQjJ07Gq
#Alzheimers#Pharmacy#fda
The @US_FDA approval of #aducanumab for the treatment of patients with #Alzheimers has been debated, Pamela Spicer, our senior analyst, said its approval is a momentous occasion for this patient population when she spoke to @Pharmacy_Times:
https://t.co/pnsRwVsxUF
*Free E-Book*
In #2020 the top 10 pharmaceuticals' revenues surpassed $100 Billion. Despite #Covid19 all but one has proved to be truly pandemic-proof and achieve growth:
https://t.co/pLoljmjxoq
#pharma#pharmaceuticals#drugpricing#drugdevelopment
*In the News*
Pamela Spicer speaks all things Alzheimer's!!!
Pamela Spicer is our senior analyst with Datamonitor Healthcare and recently interviewed with @Pharmacy_Times.
Check it out:
https://t.co/5fmYVAF41T
#alzheimers#pharmacy#healthcare @Pharma_Intell
*Free E-Book*
In #2020 the top 10 pharmaceuticals' revenues surpassed $100 Billion. Despite #Covid19 all but one has proved to be truly pandemic-proof and achieve growth:
https://t.co/ZzSzhhA0Dm
#pharma#pharmaceuticals#drugpricing#drugdevelopment
Understand #drugdevelopment risk profiles & assess competitive landscapes to help give your clients the most informed perspective with #PharmaIntelligence Financial Services Suite. Request a demo here https://t.co/ODX2HflSBH
Is the data informing your strategy up to date? Is it customized to your market? If not, find out more about how @Pharma_Intell #FinancialServices can help you. Learn more here https://t.co/RTxDz3RrXL
Get global #pipeline trial data, disease & clinical data analysis & more with the #FinancialServices suite from #PharmaIntelligence. Click to request a free demo https://t.co/SYF0tA2pA8
Get unique competitor insights in #pharma with our detailed reviews of #clinicaltrials and ability to track all drugs in development with the #FinancialServices suite from #PharmaIntelligence. Get your demo here today https://t.co/OpBlAIbbzP
With forward-looking perspectives that include catalyst tracking & regulatory success metrics. Think ahead with the #FinancialServices Suite from #PharmaIntelligence. Request a free demo here https://t.co/MZYvxdmVNE
Think ahead with the #FinancialServices Suite from @Pharma_Intell and respond to market events & anticipate changes by tracking updates that impact the #pharma industry. Learn more here https://t.co/zEiuOvifbB
Get expert analysis on #clinical development success rates covering 2011-2020, including comparisons of success rates across indications & modalities. Download your copy here https://t.co/uu9f5JpHTe
Get access to the latest report on industry #clinical success rates developed by expert from BIO, #PharmaIntelligence & #QLSAdvisors. Download your free report here https://t.co/CRwBNOFfVb
Did you know that #HPV 16 & 18 are responsible for causing around 70% of all #cervicalcancers globally? Learn more in our latest #disease analysis reports from the #ReportStore https://t.co/NttFYlVSuE
Stay up to date with the latest insights & news from #PharmaIntelligence with our #podcasts. Now available on all major streaming channels. Click here to find out more & start listening! https://t.co/RdANGklH76
Looking to stay up to date with the latest insights & news from #PharmaIntelligence? Subscribe to our #podcasts. Now available on #Spotify! https://t.co/rrv9aUiYxF
Today is #WorldAidsDay which raises awareness of the millions living with #HIV & #AIDS. We are offering 20% off reports including our indepth #disease analysis & forecast until 2027 report. Click here to take advantage of this offer https://t.co/9twatsZHSn